1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,158 | 0,179 | 07:54 | |
| 0,158 | 0,179 | 07:30 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10.11.25 | BRII-B (02137): VOLUNTARY ANNOUNCEMENT PRESENTS LATE-BREAKING DATA FROM ONGOING PHASE 2 ENSURE STUDY AT AASLD 2025 | 1 | HKEx | ||
| 07.11.25 | BRII-B (02137): VOLUNTARY ANNOUNCEMENT PUBLICATION OF PHASE 2 ENSURE STUDY RESULTS IN NATURE MEDICINE | - | HKEx | ||
| 31.10.25 | BRII-B (02137): GRANT OF SHARE OPTIONS | 1 | HKEx | ||
| 28.10.25 | BRII-B (02137): GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS | 1 | HKEx | ||
| 27.10.25 | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 18.09.25 | BRII-B (02137): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 18.09.25 | BRII-B (02137): NOTIFICATION LETTER AND CHANGE REQUEST FORM FOR REGISTERED SHAREHOLDERS | - | HKEx | ||
| BRII BIOSCIENCES Aktie jetzt für 0€ handeln | |||||
| 18.09.25 | BRII-B (02137): 2025 INTERIM REPORT | - | HKEx | ||
| 17.09.25 | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 27.08.25 | BRII-B (02137): SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUAL REPORT FOR THE YEAR ENDED DECEMBER 31, 2024 | 3 | HKEx | ||
| 25.08.25 | Leerink Partners raises Brii Biosciences stock price target to HK$2.00 on HBV data | 2 | Investing.com | ||
| 25.08.25 | BRII-B (02137): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 21.08.25 | Brii Biosciences reports 1H results | 1 | Seeking Alpha | ||
| 21.08.25 | Brii Biosciences Limited: Brii Biosciences Provides Corporate Updates and Reports 2025 Interim Financial Results | 128 | PR Newswire | Multiple Ongoing Phase 2b Studies Advancing HBV Functional Cure Strategy
Greater China Partnership with Joincare to Accelerate Development of Critical Care Antibiotic... ► Artikel lesen | |
| 21.08.25 | BRII-B (02137): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2025 | 1 | HKEx | ||
| 11.08.25 | BRII-B (02137): DATE OF BOARD MEETING | 1 | HKEx | ||
| 30.03.25 | Brii Biosciences Limited: Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179's Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification | 142 | PR Newswire | Preliminary data from Cohort 4 of the ENSURE study supports a novel enrichment strategy to utilize BRII-179 to identify patients who are immune responders and... ► Artikel lesen | |
| 21.03.25 | Brii Biosciences Limited: Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results | 593 | PR Newswire | Strategic Acquisition of Intellectual Property of BRII-179, a Wholly Owned Phase 2b Asset Capable of Combining with Multiple HBV Treatment Modalities for Cure
Data... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIOGEN | 145,90 | 0,00 % | ROUNDUP/Aktien New York Schluss: Verluste - Tech-Werte und Banken belasten | NEW YORK (dpa-AFX) - Die US-Aktienmärkte haben zur Wochenmitte an ihre Abwärtstendenz vom Vortag angeknüpft. Dabei führten schwer gewichtete Technologiewerte die Liste der Verlierer an. Ebenfalls in... ► Artikel lesen | |
| ILLUMINA | 130,54 | 0,00 % | Illumina Gets Reimbursement For FDA-Approved TruSight Oncology Comprehensive Test, Stock Down | SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN), Tuesday announced that the Centers for Medicare and Medicaid Services or CMS has granted reimbursement for the company's FDA-approved in vitro diagnostic... ► Artikel lesen | |
| NANOREPRO | 1,570 | 0,00 % | NanoRepro ordnet Aufsichtsrat nach außerordentlicher HV neu | Die Aktionäre der NanoRepro AG haben auf der außerordentlichen Hauptversammlung vom 16. Januar 2026 den Aufsichtsrat neu zusammengesetzt. Neu gewählt wurden Gunter Heneis, Michael Herrmann und Konstantin... ► Artikel lesen | |
| BRAIN BIOTECH | 2,310 | -3,35 % | Freenet Aktie: Bald Ausbruch? - BRAIN Biotech, Hensoldt, PNE, Renk und Rheinmetall im Marktbericht Börse Frankfurt | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
| BIONXT SOLUTIONS | 0,288 | +3,60 % | BioNxt berichtet über erfolgreiche finale In-vivo-Dosierungsstudienergebnisse, die eine überlegene Bioverfügbarkeit des sublingualen Cladribin-ODF bestätigen | VANCOUVER, BC / ACCESS Newswire /
19. Januar 2026 / BioNxt Solutions Inc. ("BioNxt" oder das "Unternehmen") (CSE:BNXT) (OTCQB:BNXTF) (FWB:BXT), ein innovatives
Biowissenschaftsunternehmen,... ► Artikel lesen | |
| INFLARX | 0,859 | -0,17 % | Weekly Buzz: ARS Pharma's Neffy Goes East, SLS Advances, A Signal Of Hope For IFRX? | LONDON (dpa-AFX) - Despite the typical year-end slowdown, the week saw a steady stream of high-impact news, highlighted by global approvals, clinical trial readouts, new product launches, and... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem Corp.: Sirona Biochem Update to Shareholders on Financial Status and Operations | VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) ("Sirona") wishes to provide shareholders with a critical update on the company's financial... ► Artikel lesen | |
| DEFENCE THERAPEUTICS | 0,378 | +1,07 % | Defence Therapeutics Inc.: Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics | Montreal, Quebec--(Newsfile Corp. - January 21, 2026) - Defence Therapeutics Inc., (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company, today... ► Artikel lesen | |
| TREVENA | 2,280 | -40,00 % | Hollywood Changemaker Oliver Trevena Joins Little Kitchen Academy as Investor | LOS ANGELES, CA / ACCESS Newswire / August 21, 2025 / Little Kitchen Academy (LKA), the premier Montessori-inspired cooking academy for children and teens ages 3-18, is proud to announce that Oliver... ► Artikel lesen | |
| BURCON NUTRASCIENCE | 1,060 | -7,02 % | Burcon NutraScience Corporation: Burcon Increases Non-Brokered Private Placement of Convertible Debentures to $6.9 Million | Vancouver, British Columbia--(Newsfile Corp. - January 9, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based... ► Artikel lesen | |
| TME PHARMA | 0,051 | +2,02 % | TME Pharma NV: TME Pharma provides update on its activities | TME Pharma provides update on its activities Berlin, Germany, January 5, 2025, 08.00 CET - TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the... ► Artikel lesen | |
| CYTODYN | 0,220 | -4,35 % | CytoDyn Inc.: December 2025 Letter to Shareholders | VANCOUVER, Washington, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Dear Shareholders, As we close out the year and step with confidence and purpose into 2026, I want to extend my sincere appreciation for your... ► Artikel lesen | |
| IMMUNIC | 0,552 | -2,65 % | EQS-News: Immunic AG: Immunic Highlights 2025 Accomplishments and Upcoming Milestones | Issuer: Immunic AG
/ Key word(s): Miscellaneous/Conference
Immunic Highlights 2025 Accomplishments and Upcoming Milestones
07.01.2026 / 12:30 CET/CEST
The issuer is... ► Artikel lesen | |
| IOVANCE BIOTHERAPEUTICS | 2,118 | -1,58 % | Iovance Biotherapeutics, Inc.: Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | ||
| PHIO PHARMACEUTICALS | 1,040 | -3,70 % | Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Key Tumor Response Data from all Cohorts in Intratumoral PH-762 Dose Escalation Cutaneous Carcinoma Trial | Pathology data indicate 70% overall response rate for squamous cell carcinomas: 100% clearance in 10 out of 14 responders Favorable safety and tolerability at all dose escalations King of Prussia... ► Artikel lesen |
Das Unternehmen BRII BIOSCIENCES LTD kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,158 Euro und damit -5,95 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BRII BIOSCIENCES LTD finden Sie auf Wallstreet Online.